- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1750EUR$2,000USD£1,522GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Report
- December 2025
- 150 Pages
Global
From €3369EUR$3,850USD£2,929GBP
€4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 150 Pages
Global
From €3369EUR$3,850USD£2,929GBP
€4245EUR$4,850USD£3,690GBP
- Report
- August 2025
- 150 Pages
Global
From €3369EUR$3,850USD£2,929GBP
€4245EUR$4,850USD£3,690GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,284USD£3,149GBP
- Report
- October 2025
- 160 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- August 2025
- 199 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- September 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- February 2026
- 278 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- October 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- February 2025
- 135 Pages
Global
From €15749EUR$17,995USD£13,690GBP
- Report
- January 2024
- 150 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- August 2022
- 120 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- April 2024
- 115 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- March 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- December 2024
- 152 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- December 2024
- 30 Pages
Global
From €2407EUR$2,750USD£2,092GBP
- Report
- December 2024
- 30 Pages
Global
From €2407EUR$2,750USD£2,092GBP
- Report
- December 2024
- 30 Pages
Global
From €2407EUR$2,750USD£2,092GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more